Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
Clinical trial NCT07327398 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07327398
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-07
- Primary completion
- 2026-09-30
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.